Nurix Therapeutics (NRIX) Share-based Compensation (2019 - 2026)
Nurix Therapeutics' Share-based Compensation was $10.78 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 10.3% from $9.77 million a year earlier but down 5.4% from the prior quarter.
Nurix Therapeutics (NRIX) Share-based Compensation (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nurix Therapeutics' Share-based Compensation was $40.66 million through Aug 31, 2026, up 8.7% year-over-year; for FY2025 (ended Nov 30, 2025), it was $37.97 million, up 11.9% from FY2024.
- Share-based Compensation has now increased for six consecutive fiscal years, with a five-year compound annual growth rate of 54.6% (FY2020 to FY2025).
- In earlier fiscal years, Share-based Compensation was $33.93 million in FY2024 (+0.8%), $33.67 million in FY2023 (+19.7%), $28.13 million in FY2022 (+78.0%) and $15.8 million in FY2021 (+267.4%).
- Quarterly Share-based Compensation has moved between $4.84 million (fiscal Q4 2021) and $11.39 million (fiscal Q2 2026) over five years.
- Compared with a year earlier, Share-based Compensation has increased for ten straight quarters, with growth averaging 10.1% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was fiscal Q1 2022 (growth of 124.9%); the worst was fiscal Q1 2024 (a decline of 7.8%).
- Per Business Quant data, NRIX's Share-based Compensation in the three fiscal quarters before Q3 2026 was $11.39 million (Q2 2026), $9.4 million (Q1 2026) and $9.09 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 10.78 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 10.78 Mn |
| May 31, 2026 | 11.39 Mn |
| Feb 28, 2026 | 9.40 Mn |
| Nov 30, 2025 | 9.09 Mn |
| Aug 31, 2025 | 9.77 Mn |
| May 31, 2025 | 10.39 Mn |
| Feb 28, 2025 | 8.72 Mn |
| Nov 30, 2024 | 8.51 Mn |
| Aug 31, 2024 | 8.75 Mn |
| May 31, 2024 | 8.85 Mn |
| Feb 29, 2024 | 7.82 Mn |
| Nov 30, 2023 | 8.02 Mn |
| Aug 31, 2023 | 8.45 Mn |
| May 31, 2023 | 8.72 Mn |
| Feb 28, 2023 | 8.48 Mn |
| Nov 30, 2022 | 8.30 Mn |
| Aug 31, 2022 | 6.99 Mn |
| May 31, 2022 | 6.78 Mn |
| Feb 28, 2022 | 6.07 Mn |
| Nov 30, 2021 | 4.84 Mn |
Nurix Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();